Total Funding
67
48
Total FundingPost-IPO Debt raised
Growth Score
-20 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
28723
NFL Biosciences is a biotech which develops botanical drugs for the treatment of dependencies and addictions.
- Bruno Lafont: Co-Founder and CEOPast Role: PCM, Founder and President
- Yannick Pletan: Chief Medical OfficerPast Role: Pfizer, VP of Head of Medical & Scientific Division
About the Company
NFL Biosciences is a biotechnology company. They develop a naturally based addiction withdrawal solution to help smokers willing to quit in their battle.
